Seizert Capital Partners’s Merck MRK Stock Holding History

Seizert Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$509K	Buy	4,230 +510	+14%	+$58.9K	0.02%	123
2025 Q4	$392K	Hold	3,720	–	–	0.02%	136
2025 Q3	$312K	Hold	3,720	–	–	0.01%	149
2025 Q2	$294K	Hold	3,720	–	–	0.01%	153
2025 Q1	$334K	Hold	3,720	–	–	0.02%	135
2024 Q4	$370K	Hold	3,720	–	–	0.02%	131
2024 Q3	$422K	Hold	3,720	–	–	0.02%	130
2024 Q2	$461K	Hold	3,720	–	–	0.02%	130
2024 Q1	$491K	Hold	3,720	–	–	0.02%	132
2023 Q4	$406K	Hold	3,720	–	–	0.02%	136
2023 Q3	$383K	Hold	3,720	–	–	0.02%	139
2023 Q2	$429K	Hold	3,720	–	–	0.02%	137
2023 Q1	$396K	Hold	3,720	–	–	0.02%	147
2022 Q4	$413K	Hold	3,720	–	–	0.02%	168
2022 Q3	$320K	Hold	3,720	–	–	0.02%	172
2022 Q2	$339K	Hold	3,720	–	–	0.02%	182
2022 Q1	$305K	Hold	3,720	–	–	0.01%	190
2021 Q4	$285K	Hold	3,720	–	–	0.01%	193
2021 Q3	$279K	Hold	3,720	–	–	0.01%	186
2021 Q2	$289K	Sell	3,720 -179	-5%	-$13.3K	0.01%	190
2021 Q1	$287K	Hold	3,899	–	–	0.02%	173
2020 Q4	$304K	Sell	3,899 -268	-6%	-$20.5K	0.02%	154
2020 Q3	$330K	Hold	4,167	–	–	0.02%	146
2020 Q2	$307K	Hold	4,167	–	–	0.02%	156
2020 Q1	$306K	Sell	4,167 -10,018	-71%	-$787K	0.02%	148
2019 Q4	$1.23M	Sell	14,185 -1,045	-7%	-$85.8K	0.06%	123
2019 Q3	$1.22M	Sell	15,230 -294	-2%	-$23.6K	0.06%	114
2019 Q2	$1.24M	Sell	15,524 -4,326	-22%	-$331K	0.06%	119
2019 Q1	$1.57M	Sell	19,850 -956	-5%	-$71.5K	0.07%	111
2018 Q4	$1.52M	Sell	20,806 -245	-1%	-$17.3K	0.07%	112
2018 Q3	$1.43M	Sell	21,051 -17,269	-45%	-$1.1M	0.05%	125
2018 Q2	$1.99M	Hold	38,320	–	–	0.07%	105
2018 Q1	$1.99M	Sell	38,320 -2,358	-6%	-$127K	0.07%	105
2017 Q4	$2.18M	Sell	40,678 -856	-2%	-$47.5K	0.08%	104
2017 Q3	$2.54M	Sell	41,534 -9,639	-19%	-$584K	0.09%	102
2017 Q2	$3.13M	Sell	51,173 -2,262	-4%	-$138K	0.11%	89
2017 Q1	$3.24M	Sell	53,435 -2,202	-4%	-$134K	0.12%	81
2016 Q4	$3.13M	Sell	55,637 -2,414	-4%	-$141K	0.11%	104
2016 Q3	$3.46M	Sell	58,051 -4,318	-7%	-$253K	0.13%	88
2016 Q2	$3.43M	Hold	62,369	–	–	0.13%	89
2016 Q1	$3.15M	Sell	62,369 -442,970	-88%	-$21.7M	0.11%	107
2015 Q4	$25.5M	Sell	505,339 -16,541	-3%	-$834K	0.79%	49
2015 Q3	$24.6M	Sell	521,880 -40,940	-7%	-$2.17M	0.75%	51
2015 Q2	$30.6M	Sell	562,820 -23,440	-4%	-$1.31M	0.78%	54
2015 Q1	$32.2M	Sell	586,260 -347,038	-37%	-$19.7M	0.81%	52
2014 Q4	$50.6M	Sell	933,298 -46,145	-5%	-$2.57M	1.07%	44
2014 Q3	$55.4M	Buy	979,443 +5,726	+0.6%	+$322K	1.11%	44
2014 Q2	$53.8M	Buy	973,717 +74,018	+8%	+$4.04M	1.07%	45
2014 Q1	$48.7M	Sell	899,699 -16,519	-2%	-$855K	1.14%	44
2013 Q4	$43.8M	Buy	916,218 +143,253	+19%	+$6.55M	1.04%	48
2013 Q3	$35.1M	Buy	772,965 +34,719	+5%	+$1.59M	0.96%	49
2013 Q2	$32.7M	Buy	+738,246	New	+$33M	0.89%	51

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seizert Capital Partners's MRK Position: Q1 2026 in Review

Seizert Capital Partners increased its Merck (MRK) stake by 14% in Q1 2026, buying an estimated $58.9K and bringing the position to 4,230 shares worth $509K. The position accounts for 0.02% of the portfolio, ranked #123.

Seizert Capital Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.4M in Q3 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Seizert Capital Partners held 4,230 shares of Merck worth $509K as of Q1 2026.
Seizert Capital Partners bought 510 Merck shares in Q1 2026, an estimated $58.9K.
Merck made up 0.02% of Seizert Capital Partners's portfolio in Q1 2026, its #123 holding.
Seizert Capital Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Seizert Capital Partners's Merck position peaked at $55.4M in Q3 2014.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.